PHELINUN

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania

Active ingredients

The drug PHELINUN contains one active pharmaceutical ingredient (API):

1 Melphalan
UNII 1VXP4V453T - MELPHALAN HYDROCHLORIDE

Melphalan is a bifunctional alkylating agent. Formation of carbonium intermediates from each of the two bis-2-chloroethyl groups enables alkylation through covalent binding with the 7-nitrogen of guanine on DNA, cross-linking the two DNA strands and thereby preventing cell replication.

Read about Melphalan

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PHELINUN Powder and solvent for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01AA03 Melphalan L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1832611, 1832622
Country: FR Base de données publique des médicaments Identifier(s): 64885172, 67259768
Country: IT Agenzia del Farmaco Identifier(s): 049241019, 049241021
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1091478, 1091479
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100445845, 100445851
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67922001, W67923001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.